You have 9 free searches left this month | for more free features.

Lymphoid Leukemia

Showing 1 - 25 of 6,227

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

H19 in Acute Lymphoblastic Leukemia.

Not yet recruiting
  • Acute Lymphoid Leukemia
    • (no location specified)
    Jul 11, 2023

    Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

    Recruiting
    • Acute Lymphoid Leukemia
    • +3 more
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de Sao Paulo
    Jul 24, 2023

    Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

    Not yet recruiting
    • Breast Cancer
    • +9 more
    • Assessment tool IA3-CP with SDoH
    • Assessment tool IA3-CP without SDoH
    • (no location specified)
    May 22, 2023

    Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children Trial in Tours (Biological sampling in patients, Biological sampling

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Acute Myeloid Leukemia in Children
    • Biological sampling in patients
    • Biological sampling in control patients
    • Tours, France
    • +2 more
    Mar 17, 2023

    Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

    Active, not recruiting
    • Recurrent Chronic Lymphoid Leukemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 19, 2022

    Pediatric and Young Adult B-Cell Malignancies After Commercially

    Not yet recruiting
    • Lymphoid Leukemia
    • Questionnaire for patients receiving therapy
    • Palo Alto, California
      Stanford University
    May 9, 2023

    Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

    Active, not recruiting
    • Lymphoid Leukemia
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Dec 30, 2022

    Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib)

    Not yet recruiting
    • Philadelphia-Positive ALL
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Jul 1, 2023

    ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

    Not yet recruiting
    • ALL, Childhood B-Cell
    • +2 more
    • Tafasitamab
    • (no location specified)
    Nov 25, 2022

    Acute Lymphoid Leukemia Trial in Seoul (Blincyto)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Seoul, Gangnam-gu, Korea, Republic of
    • +4 more
    Apr 12, 2023

    Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

    Completed
    • Lymphoid Leukemia
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Jan 30, 2023

    Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia Trial in Beijing

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • chimeric antigen receptor T cell
    • Beijing, Beijing, China
      Beijing Boren Hospital
    Aug 12, 2022

    Acute Lymphoid Leukemia Trial in Philadelphia (huCART19)

    Recruiting
    • Acute Lymphoid Leukemia
    • huCART19
    • Philadelphia, Pennsylvania
      Children's Hospital of Pennsylvania
    Jul 21, 2022

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Orca-Q
    • Gainesville, Florida
      University of Florida
    Aug 26, 2022

    Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Acute Lymphoblastic Leukemia
    • CD19 Directed CAR T Cell
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 12, 2022

    Immune Reconstitution After Allo-HSCT and Blinatumomab

    Not yet recruiting
    • Leukemia, Lymphoid
    • (no location specified)
    Oct 3, 2023

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 27, 2023

    Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Personalized rATG (P-rATG)
    • +7 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Aug 31, 2022

    Pediatric Acute Myeloid Leukemia, Pediatric Acute Lymphoid Leukemia, Pediatric Non-Hodgkin Lymphoma Trial in Kuala Lumpur

    Not yet recruiting
    • Pediatric Acute Myeloid Leukemia
    • +3 more
    • eHOPE
    • Usual care
    • Kuala Lumpur, Malaysia
    • +1 more
    Jul 7, 2022

    Bone and Joints, Brain and Nervous System, Leukemia, NOS Trial in San Francisco (GOLD Program, Treatment as usual (TAU))

    Recruiting
    • Bone and Joints
    • +4 more
    • GOLD Program
    • Treatment as usual (TAU)
    • San Francisco, California
      Stanford Cancer Institute
    Jun 8, 2022

    Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector

    Not yet recruiting
    • Lymphoid Leukemia
    • Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
    • Treg CD34+ HSPC (Orca-T)
    • Palo Alto, California
      Stanford Cancer Center
    Aug 17, 2022

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Not yet recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 3, 2023

    Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

    Recruiting
    • Non Hodgkin Lymphoma
    • +2 more
    • Fully human anti CD19 CAR-T Cell Dose
    • +2 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Oct 4, 2022

    Acute Lymphoid Leukemia Trial in Spain (ARI-0001 cells)

    Recruiting
    • Acute Lymphoid Leukemia
    • ARI-0001 cells
    • Badalona, Barcelona, Spain
    • +9 more
    Feb 3, 2022

    Chronic Lymphoid Leukemia in Relapse Trial in Tuebingen (Belimumab 200 MG/ML [Benlysta], standard of care)

    Recruiting
    • Chronic Lymphoid Leukemia in Relapse
    • Belimumab 200 MG/ML [Benlysta]
    • standard of care
    • Tuebingen, BW, Germany
      University Hospital Tuebingen, CCU Translational Immunology
    Feb 2, 2022